Related Experiment Video
Updated: May 27, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Iron depletion: an ameliorating factor for sickle cell disease?
P C Giordano1, W Huisman, C L Harteveld
1Hemoglobinopathies Laboratory, Department of Human and Clinical Genetics, Leiden University Medical Center, Einthovenweg 20, 2300RC Leiden, The Netherlands.
Iron depletion may benefit sickle cell disease (SCD) patients by reducing HbS and increasing HbF, potentially lessening disease severity. Further studies and iron chelation therapy are recommended for managing iron overload in SCD.
Area of Science:
- Hematology
- Molecular Biology
- Medical Practice
Background:
- Sickle cell disease (SCD) is a genetic blood disorder characterized by abnormal hemoglobin (HbS).
- Managing SCD involves addressing complications arising from the disease, including iron overload from transfusions.
- Current treatments aim to alleviate symptoms and prevent complications.
Observation:
- Two case studies observed a potential link between iron depletion and beneficial effects in SCD patients.
- Iron depletion appeared to decrease the formation of sickle hemoglobin (HbS).
- Simultaneously, iron depletion was associated with an increase in fetal hemoglobin (HbF) levels.
Findings:
- The observed reduction in HbS and increase in HbF suggests a possible mechanism for mitigating SCD severity.
- Iron depletion may favorably alter hemoglobin composition in SCD patients.
- These findings highlight the potential role of iron modulation in SCD management.
Implications:
- Further clinical studies comparing SCD patients with identical genotypes, with and without iron depletion, are warranted.
- Monitoring disease progression under controlled iron levels could validate these observations.
- Chelation therapy should be considered to manage iron overload in SCD patients, potentially improving outcomes.
Related Concept Videos
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
The Periodic Table and Organismal Elements
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Multiple Allele Traits
Erythropoiesis
